Researcher in Immunotherapy of cancer
- Section of Cellular Therapy, Translational Research Unit, Oslo University Hospital- (in new tab)
- About the position
**One researcher 100 % position in Immunotherapy of cancer: “4KAPAI: Fourth generation-K101CAR-based pancreatic ductal adenocarcinoma Immunotherapy” is available for a duration of three years. The project is supported by Norwegian Cancer Society.**Starting date latest September 2026.**
Key information
- Application deadline:
** **
- Employer:
**Oslo universitetssykehus HF**
- Town/city:
**Oslo**
- Title:
**Researcher**
- Positions:
**1**
- Full-time/part-time:
**Full-time**
- Employment type:
**Contract**
- Percentage of full-time:
**100**
- Webcruiter ID:
** **
- Social sharing:
- Share on x- Share on LinkedIn- Share on Facebook- Project description:
Chimeric Antigen Receptor (CAR) therapies have demonstrated remarkable clinical efficacy in otherwise fatal...